Study Suggests Some Treatment For Early Breast Cancer Is Unnecessary

“Study Suggests Some Treatment For Early Breast Cancer Is Unnecessary,” by Rob Stein, NPR.

Nearly 70,000 women are diagnosed with DCIS each year. DCIS is an overgrowth of cells within the lining of the milk ducts. Such growths are not dangerous unless they break through and invade other breast tissue and ultimately spread to lymph . . . → Read More: Study Suggests Some Treatment For Early Breast Cancer Is Unnecessary

Should We Rename DCIS?

Ductal carcinoma in situ was all over the news this week, after the Journal of the American Medical Association published “Overdiagnosis and Overtreatment in Cancer, An Opportunity for Improvement.” This is a good, and necessary, conversation. DCIS was front and center as one of the prime candidates for overtreatment, and the panel proposed renaming it . . . → Read More: Should We Rename DCIS?

What’s In A Name? Cancer – or Indolent Lesions of Epithelial Origin

“What’s In A Name? Cancer – or Indolent Lesions of Epithelial Origin.” By Jody Schoger, Michael S. Cowher, M.D., and Deanna J. Attai, M.D., F.A.C.S., BCSMCommunity.org.

What’s in a name? In the case of cancer, there are myths, fears and misinformation – more than perhaps any other illness. Cancer encompasses hundreds of different diseases and . . . → Read More: What’s In A Name? Cancer – or Indolent Lesions of Epithelial Origin

Book Review and Analysis -- From Zero to Mastectomy: What I Learned and You Need to Know About Stage 0 Breast Cancer

At age 52, Jackie Fox was diagnosed with DCIS, ductal carcinoma in situ, a form of breast cancer labeled stage zero, compared to stages 1 to 4. This slim book is an up-close and personal story of Fox’s roller coaster journey — from the moment her doctor gave her the diagnosis, telling her it was . . . → Read More: Book Review and Analysis — From Zero to Mastectomy: What I Learned and You Need to Know About Stage 0 Breast Cancer

“Carcinoma”: What’s in a name?

As part of a National Cancer Institute working group, Dr. Laura J. Esserman MD, MBA of Mt Zion Carol Franc Buck Breast Cancer Center along with colleagues Ian Thompson MD of the University of Texas Health Science Center at San Antonio and Brian Reid MD, PhD of Fred Hutchinson Cancer Research Center in Seattle, Washington, . . . → Read More: “Carcinoma”: What’s in a name?

Definition of Cancer Should Be Tightened, Scientists Say

“Definition of Cancer Should Be Tightened, Scientists Say.” By Tara Parker-Pope, The New York Times.

A group of experts advising the nation’s premier cancer research institution has recommended sweeping changes in the approach to cancer detection and treatment, including changes in the very definition of cancer and eliminating the word entirely from some common diagnoses.

. . . → Read More: Definition of Cancer Should Be Tightened, Scientists Say

Our Feel-Good War on Breast Cancer: MBCN Responds

“Our Feel-Good War on Breast Cancer: MBCN Responds.” By Katherine O’Brien, MBCN Secretary, Metastatic Breast Cancer Network.

Editor’s Note: Peggy Orenstein’s April 25, 2013 article–the cover story for this Sunday’ s New York Times’ Magazine, demonstrates a remarkable depth and thoughtfulness. It is long–but well-worth the effort to read. For those looking for a quick . . . → Read More: Our Feel-Good War on Breast Cancer: MBCN Responds

Our Feel-Good War on Breast Cancer

“Our Feel-Good War on Breast Cancer.” By Peggy Orenstein, The New York Times Magazine.

I used to believe that a mammogram saved my life. I even wrote that in the pages of this magazine. It was 1996, and I had just turned 35 when my doctor sent me for an initial screening — a . . . → Read More: Our Feel-Good War on Breast Cancer

Are Pricey Computer-Aided Mammograms Worth It?

“Are Pricey Computer-Aided Mammograms Worth It?” By Christine Norton and Karen Sepucha, Health News Review).

Health News Review evaluates health reporting on medical interventions from the top ten circulating newspapers in the United States. The evaluation is based on established criteria related to costs of the intervention, quantification of benefits and harms, critical evaluation of . . . → Read More: Are Pricey Computer-Aided Mammograms Worth It?

Effect of three decades of screening mammography on breast-cancer incidence

“Effect of three decades of screening mammography on breast-cancer incidence.” By A. Bleyer and H.G. Welch, New England Journal of Medicine

A study published in the New England Journal of Medicine concludes that one-third of all newly diagnosed breast cancers are the result of overdiagnosis, and screening is having a marginal effect on the breast . . . → Read More: Effect of three decades of screening mammography on breast-cancer incidence